REVELATION BIOSCIENCES, INC. Quarterly General and Administrative Expense in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Revelation Biosciences, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q4 2019 to Q3 2024.
  • Revelation Biosciences, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $966K, a 14.3% decline year-over-year.
  • Revelation Biosciences, Inc. General and Administrative Expense for the twelve months ending September 30, 2024 was $4.54M, a 10.2% increase year-over-year.
  • Revelation Biosciences, Inc. annual General and Administrative Expense for 2023 was $4.51M, a 17.8% decline from 2022.
  • Revelation Biosciences, Inc. annual General and Administrative Expense for 2022 was $5.49M, a 8.96% increase from 2021.
  • Revelation Biosciences, Inc. annual General and Administrative Expense for 2021 was $5.04M, a 3361% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $966K -$161K -14.3% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.13M +$104K +10.1% Jun 30, 2024 10-Q/A 2024-09-23
Q1 2024 $1.18M +$90K +8.22% Mar 31, 2024 10-Q/A 2024-09-23
Q4 2023 $1.27M +$388K +44.1% Dec 31, 2023 10-K/A 2024-09-23
Q3 2023 $1.13M +$309K +37.7% Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.02M +$139K +15.7% Jun 30, 2023 10-Q/A 2024-09-23
Q1 2023 $1.09M -$1.81M -62.3% Mar 31, 2023 10-Q/A 2024-09-23
Q4 2022 $878K -$313K -26.3% Dec 31, 2022 10-K/A 2024-09-23
Q3 2022 $818K -$693K -45.9% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $885K -$398K -31% Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $2.91M +$1.86M +177% Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $1.19M +$1.92M Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.51M +$643K +74.1% Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.28M +$1.28M Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.05M +$1.04M +14574% Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$730K -$734K -20171% Dec 31, 2020 10-K 2022-04-15
Q3 2020 $868K Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $521* Jun 30, 2020 10-Q 2021-08-23
Q1 2020 $7.16K Mar 31, 2020 10-Q 2021-06-22
Q4 2019 $3.64K Dec 31, 2019 10-K/A 2021-06-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.